NCT03561207 2023-03-24
3D-PREDICT
KIYATEC
Unknown
Clinical Trials
5 trialsNCT02654340 2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
NCT00705198 2016-11-15
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Merck Sharp & Dohme LLC
Completed
NCT00723827 2015-01-30
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Completed
NCT00561873 2007-11-21
Nimotuzumab in Children With HGG
Oncoscience AG
Completed